Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698529 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations
A Phase 2 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 99
- Enrollment target
NCT00698529: Completed Phase 2 study, sponsored by Medical College of Wisconsin.
NCT00698529 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 99 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (26% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00698529, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 99 participants
- Enrollment target
Study Summary
This study will compare the effectiveness of face-to-face training versus Web-based training seminars in disseminating HIV prevention interventions to nongovernmental organizations in Eastern Europe and Central Asia.
Interventions
- BEHAVIORAL Face-to-face training
- BEHAVIORAL Distance training
- BEHAVIORAL Popular Opinion Leader (POL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2008-11 |
| Est. Completion | 2019-07-01 |
| Phase | Phase 2 |
What the finished NCT00698529 record still lists
NCT00698529 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (26% lower).
The record links to 0 conditions, and to 3 interventions - of which Face-to-face training is the first listed.
NCT00698529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00698529 about?
NCT00698529 is a clinical study titled "Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations". This study will compare the effectiveness of face-to-face training versus Web-based training seminars in disseminating HIV prevention interventions to nongovernmental organizations in Eastern Europe and Central Asia.
What is the current status of trial NCT00698529?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 99 participants. The study started on 2008-11. Estimated completion is 2019-07-01.
What interventions are being tested in trial NCT00698529?
The interventions under investigation include: Face-to-face training (BEHAVIORAL), Distance training (BEHAVIORAL), Popular Opinion Leader (POL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00698529?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00698529's enrollment target sits among peer trials
99 738th of 2000 higher than 1,258 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia